Solarea Bio News Today

There is growing evidence that a relative abundance of certain gut microbes may be related to skeletal health, according to a new study published in Frontiers in Endocrinology. If confirmed by additional research, the findings could provide the opportunity to alter gut microbiomes to achieve better bone health, as scientists learn more about “osteomicrobiology,” a new term recently used to characterize this relationship.

The NIH/National Institute on Aging has awarded a R01 $3 million grant to study the impact of a probiotic/prebiotic (synbiotic) medical food developed by Solarea Bio on maintaining bone health of older women.

The cash injection will go toward two new products with plans to introduce a stream of future products that address important health conditions.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Solarea Bio, a clinical stage biotech company, has been selected as an awardee of the NAM Healthy Longevity 2022 QuickFire Challenge, launched...

/PRNewswire/ -- Solarea Bio, a startup company dedicated to delivering healthcare products derived from the microbiome of fresh produce announces the...

/PRNewswire/ -- Solarea Bio, a biotechnology company in Cambridge, Mass., and leading researchers at Harvard Medical School affiliated Hebrew SeniorLife, New...

/PRNewswire/ -- Solarea Bio, a biotechnology company in Cambridge, Mass., and leading researchers at Harvard Medical School affiliated Hebrew SeniorLife, New...

For the readers interested in the stock health of Archer-Daniels-Midland Company (ADM). It is currently valued at $64.84. When the transactions were called off in the previous session, Stock hit the highs of $65.26, after setting-off with the price of $64.84. Company’s stock value dipped to $64.30

/PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, today announced it has...